TANK-binding kinase 1 as a novel therapeutic target for viral diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TANK-binding kinase 1 as a novel therapeutic target for viral diseases

Published:2019-04-10 Issue:5 Volume:23 Page:437-446
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Zhao Chunyuan¹²³,Zhao Wei¹²³

Affiliation:

1. Department of Immunology, School of Basic Medical Science, Shandong University, Jinan, China

2. State Key Laboratory of Microbial Technology, Shandong University, Jinan, China

3. Department of Cell Biology, School of Basic Medical Science, Shandong University, Jinan, China

Funder

the National Natural Science Foundation of China

the Fundamental Research Funds of Shandong University

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2019.1601702

Reference119 articles.

1. NF-kappa B activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase

2. NAK is an IκB kinase-activating kinase

3. IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex

4. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway

5. IKKε and TBK1 are essential components of the IRF3 signaling pathway

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of TBK1 activation in cancer cells;Cell Insight;2024-10

2. Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches;International Journal of Molecular Sciences;2024-08-29

3. The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐T. Gondii Immunity and Tumor Immunotherapy;Advanced Science;2024-06-21

4. Innate Antiviral Response through Mitochondrial Antiviral Signaling Protein (MAVS) in Fish - A Review;Fish Pathology;2024-06-15

5. Role of TBK1 Inhibition in Targeted Therapy of Cancer;Mini-Reviews in Medicinal Chemistry;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3